O'Reilly Claire L, Bell J Simon, Kelly Patrick J, Chen Timothy F
Faculty of Pharmacy, Pharmacy and Bank Building A15, The University of Sydney, NSW 2006, Australia.
Faculty of Pharmacy, Pharmacy and Bank Building A15, The University of Sydney, NSW 2006, Australia; Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, University of South Australia, Adelaide, Australia; Kuopio Research Centre of Geriatric Care, University of Eastern Finland, Kuopio, Finland; Clinical Pharmacology and Geriatric Pharmacotherapy Unit, School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
Res Social Adm Pharm. 2015 May-Jun;11(3):e101-9. doi: 10.1016/j.sapharm.2013.04.006. Epub 2013 Apr 28.
Pharmacists' provision of medication counseling and medication review has been shown to improve adherence and resolve drug-related problems. Lack of knowledge of mental health conditions and negative beliefs may act as a barrier to the provision of pharmacy services. It is unclear how pharmacists' knowledge and attitudes impact their provision of pharmacy services.
To explore the relationship between pharmacists' level of mental health stigma, mental health literacy and behavioral intentions in relation to providing pharmacy services for consumers with schizophrenia.
A survey instrument containing a measure of mental health literacy, the 7-item social distance scale, and 16 items relating to the provision of pharmacy services for consumers with schizophrenia compared to cardiovascular disease, was mailed to a random sample of 1000 pharmacists registered with the Pharmacy Board of New South Wales in November 2009. Multiple linear regression models were used to assess the relationship between stigma, knowledge and behavior.
Responses were received from 188 pharmacists. Pharmacists were significantly more confident and comfortable to provide services to consumers with a cardiovascular illness than a mental illness. Social distance, β = -0.11 (95% CI: -0.22, -0.01, P = 0.03), and schizophrenia literacy scores, β = 1.02, (95% CI: 0.54, 1.50, P < 0.001), were strongly associated with willingness to provide medication counseling. Schizophrenia literacy was also a predictor of identifying drug-related problems, β = 1.09 (95% CI: 0.39, 1.79, P = 0.002).
Low levels of mental health stigma and high levels of schizophrenia literacy were associated with pharmacists being more willing to provide medication counseling and identify drug-related problems for consumers with schizophrenia. This demonstrates the importance of improving knowledge and stigma surrounding schizophrenia to improve service delivery for consumers taking medications for schizophrenia.
药剂师提供药物咨询和药物评估已被证明可提高依从性并解决药物相关问题。缺乏心理健康状况知识和负面信念可能成为提供药学服务的障碍。目前尚不清楚药剂师的知识和态度如何影响他们提供药学服务。
探讨药剂师的心理健康污名化程度、心理健康素养与为精神分裂症消费者提供药学服务的行为意图之间的关系。
2009年11月，一份包含心理健康素养测量、7项社会距离量表以及与为精神分裂症消费者而非心血管疾病消费者提供药学服务相关的16个条目的调查问卷，被邮寄给新南威尔士州药房委员会注册的1000名药剂师的随机样本。使用多元线性回归模型评估污名、知识与行为之间的关系。
收到了188名药剂师的回复。与患有精神疾病的消费者相比，药剂师为患有心血管疾病的消费者提供服务时明显更有信心且更自在。社会距离，β = -0.11（95%置信区间：-0.22，-0.01，P = 0.03），以及精神分裂症素养得分，β = 1.02（95%置信区间：0.54，1.50，P < 0.001），与提供药物咨询的意愿密切相关。精神分裂症素养也是识别药物相关问题的一个预测因素，β = 1.09（95%置信区间：0.39，1.79，P = 0.002）。
低水平的心理健康污名化和高水平的精神分裂症素养与药剂师更愿意为精神分裂症消费者提供药物咨询并识别药物相关问题相关。这表明提高对精神分裂症的认识和消除污名对于改善为服用精神分裂症药物的消费者提供的服务至关重要。
